$405.59+1.10% · 3M
Moving avg
1W-1.73%
1M-5.48%
3M+1.10%
6M+45.42%
YTD+20.57%
1Y+55.06%
3Y-20.62%
5Y-0.09%
52-week range
$234.6075% of range$461.62
Company health
Value2/6
Growth3/6
Profitability3/6
Health2/6
Dividend3/6
Bull vs bear
Strengths
- Analysts see 16% upside to a $469 target
- Analyst consensus is "Buy"
- High return on equity (1440%)
- Revenue compounding 12% a year
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$368.33B
Enterprise value
$423.95B
P/E ratio (TTM)
27.06x
P/S ratio (TTM)
0.85x
EV/EBITDA
16.46x
Per share & returns
EPS (TTM)
$15.59
Dividend yield
2.13%
Beta (1Y)
0.63
30-day change
-5.48%
Trading
Volume (24h)
2.66M
Previous close
$402.19
Shares outstanding
908.14M
About UnitedHealth Group Incorporated
Sector
Healthcare
Industry
Medical - Healthcare Plans
Exchange
NYSE
Symbol
UNH
UnitedHealth Group Incorporated is a mega-cap healthcare company in the Medical - Healthcare Plans industry. Its shares are listed on NYSE (United States) and trade under the ticker UNH.
Frequently asked questions
What is UnitedHealth Group Incorporated's market cap?
UnitedHealth Group Incorporated (UNH) has a market capitalization of $368.33B.
What is UnitedHealth Group Incorporated's P/E ratio?
UnitedHealth Group Incorporated trades at a price-to-earnings (P/E) ratio of 27.06.
What exchange does UNH trade on?
UNH trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap
Amgen Inc.AMGN
$416.18+0.45%
$224.62B cap